{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T06:06:45Z","timestamp":1788934005446,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10142-026-02041-5","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:27:10Z","timestamp":1788931630000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative pooled transcriptomic analysis reveals shared and distinct molecular signatures in adult T-cell leukemia\/lymphoma and peripheral T-cell lymphoma"],"prefix":"10.1007","volume":"26","author":[{"given":"Mohammad Mehdi","family":"Akbarin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Farjami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo Ram\u00edrez","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"2041_CR1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5045\/br.2017.52.2.106","volume":"52","author":"MM Akbarin","year":"2017","unstructured":"Akbarin MM, Shirdel A, Bari A, Mohaddes ST, Rafatpanah H, Karimani EG, Etminani K, Golabpour A, Torshizi R (2017) Evaluation of the role of TAX, HBZ, and HTLV-1 proviral load on the survival of ATLL patients. Blood Res 52:106\u2013111","journal-title":"Blood Res"},{"key":"2041_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12981-024-00664-x","volume":"21","author":"MM AKBARIN","year":"2024","unstructured":"Akbarin MM, Farjami Rezaeesa, Rahimi Z, H., Rafatpanah H (2024a) The role of CREB and MAPK signaling pathways in ATLL patients. AIDS Res Ther 21:81","journal-title":"AIDS Res Ther"},{"key":"2041_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-024-00664-x","author":"MM Akbarin","year":"2024","unstructured":"Akbarin MM, Rezaee SA, Farjami Z, Rahimi H, Rafatpanah H (2024b) The role of CREB and MAPK signaling pathways in ATLL patients. AIDS Res Ther. https:\/\/doi.org\/10.1186\/s12981-024-00664-x","journal-title":"AIDS Res Ther"},{"key":"2041_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-026-11747-5","author":"MM Akbarin","year":"2026","unstructured":"Akbarin MM, Farjami Z, Alvarez HR (2026) Stress granules at the crossroads of retroviral replication and antiviral immunity: mechanisms and therapeutic opportunities. Mol Biol Rep. https:\/\/doi.org\/10.1007\/s11033-026-11747-5","journal-title":"Mol Biol Rep"},{"key":"2041_CR5","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2016.0272","author":"CRM Bangham","year":"2017","unstructured":"Bangham CRM, Matsuoka M (2017) Human T-cell leukaemia virus type 1: parasitism and pathogenesis. Philos Trans R Soc Lond B Biol Sci. https:\/\/doi.org\/10.1098\/rstb.2016.0272","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2041_CR6","doi-asserted-by":"publisher","first-page":"101594","DOI":"10.1016\/j.bjid.2021.101594","volume":"25","author":"C BRITES","year":"2021","unstructured":"Brites C, Grassi MF, ISshak Quaresmajas, Vallinoto ACR (2021) Pathogenesis of HTLV-1 infection and progression biomarkers: An overview. Braz J Infect Dis 25:101594","journal-title":"Braz J Infect Dis"},{"key":"2041_CR7","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.927917","volume":"27","author":"F Cao","year":"2021","unstructured":"Cao F, Cheng YS, Yu L, Xu YY, Wang Y (2021) Bioinformatics analysis of differentially expressed genes and protein-protein interaction networks associated with functional pathways in ulcerative colitis. Med Sci Monit 27:e927917","journal-title":"Med Sci Monit"},{"key":"2041_CR8","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/ijc.30473","volume":"140","author":"A CARBONE","year":"2017","unstructured":"Carbone A, Gloghini A, Caruso A, De Paoli P, DOolcetti R (2017) The impact of EBV and HIV infection on the microenvironmental niche underlying Hodgkin lymphoma pathogenesis. Int J Cancer 140:1233\u20131245","journal-title":"Int J Cancer"},{"key":"2041_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23063214","author":"M Chivu-Economescu","year":"2022","unstructured":"Chivu-Economescu M, Necula LG, Matei L, Dragu D, Bleotu C, Sorop A, Herlea V, Dima S, Popescu I, Diaconu CC (2022) Collagen family and other matrix remodeling proteins identified by bioinformatics analysis as hub genes involved in gastric cancer progression and prognosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23063214","journal-title":"Int J Mol Sci"},{"key":"2041_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1049\/syb2.12054","volume":"16","author":"A DOUGHAN","year":"2022","unstructured":"Doughan A, Salifu SP (2022) Genes associated with diagnosis and prognosis of Burkitt lymphoma. IET Syst Biol 16:220\u2013229","journal-title":"IET Syst Biol"},{"key":"2041_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.957535","volume":"13","author":"H El Hajj","year":"2022","unstructured":"El Hajj H, Bazarbachi A (2022) Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia. Front Immunol 13:957535","journal-title":"Front Immunol"},{"key":"2041_CR12","first-page":"485","volume":"32","author":"E EUSEBIO-PONCE","year":"2019","unstructured":"Eusebio-Ponce E, Anguita E, Paulino-Ramirez R, Candel FJ (2019) HTLV-1 infection: An emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases. Rev Esp Quimioter 32:485\u2013496","journal-title":"Rev Esp Quimioter"},{"key":"2041_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1089\/aid.2023.0025","volume":"40","author":"Z FAJAMI","year":"2024","unstructured":"Fajami Z, Akbarin MM, Rafatpanah H, Ramezani S, Rahimi H, Rezaee SA (2024) Assessment of Bcl-xL, TAX, and HBZ Gene Expression in Adult T cell Leukemia\/Lymphoma Patients. AIDS Res Hum Retroviruses 40:141\u2013147","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2041_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-026-03282-x","author":"Z Farjami","year":"2026","unstructured":"Farjami Z, Akbarin MM (2026) Exploitation of CREB signaling by HTLV-1 and BLV: a central axis in viral persistence and leukemogenesis. Med Oncol. https:\/\/doi.org\/10.1007\/s12032-026-03282-x","journal-title":"Med Oncol"},{"key":"2041_CR15","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s11033-026-11513-7","volume":"53","author":"Z FARJAMI","year":"2026","unstructured":"Farjami Z, Akbarin MM, Alvarez HR (2026) Suppressor of cytokine signaling (SOCS) proteins in human retroviral infections. Mol Biol Rep 53:366","journal-title":"Mol Biol Rep"},{"key":"2041_CR16","first-page":"315","volume":"390","author":"JA Healy","year":"2015","unstructured":"Healy JA, Dave SS (2015) The role of EBV in the pathogenesis of diffuse large B cell lymphoma. Curr Top Microbiol Immunol 390:315\u201337","journal-title":"Curr Top Microbiol Immunol"},{"key":"2041_CR17","doi-asserted-by":"crossref","unstructured":"Iqbal J, Greiner WEISENBURGERDD, Vose TC, Mckeithan JM, Kucuk T, Geng C, Nakamura HDEFFENBACHERKSMITHLDYBKAERK, Mdelabiej SETOSBERGER, Loong F, Sng Fauwykoyh I, Armitage Jo Chan, W. C. & International Peripheral, T. C. L. P. 2010. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood, 115, 1026\u20131036","DOI":"10.1182\/blood-2009-06-227579"},{"key":"2041_CR18","first-page":"3625","volume":"9","author":"T ISHIDA","year":"2003","unstructured":"Ishida T, Iida UTSUNOMIYAA, Inagaki S, Takatsuka H, Kusumoto Y, Shimizu Stakeuchig, Ito S, Eimoto Mkomatsuhwakitaa, Matsushima T, K., Ueda R (2003) Clinical significance of CCR4 expression in adult T-cell leukemia\/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res 9:3625\u20133634","journal-title":"Clin Cancer Res"},{"key":"2041_CR19","first-page":"367","volume":"15","author":"D JAGADEESH","year":"2013","unstructured":"Jagadeesh D, Smith MR (2013) Novel targeted therapies in peripheral T cell lymphoma. Discov Med 15:367\u2013378","journal-title":"Discov Med"},{"key":"2041_CR20","doi-asserted-by":"crossref","unstructured":"Kawaguchi A, Orba Y, Kimura T, Iha H, Ogata M, Tsuji T, Ainai A, Sata T, Okamoto T, Sawa Hallww H, Hasegawa H (2009) Inhibition of the SDF-1\u03b1-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I transgenic mice Blood. 114:2961\u20132968","DOI":"10.1182\/blood-2008-11-189308"},{"key":"2041_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.153935","volume":"234","author":"T Kubo","year":"2022","unstructured":"Kubo T, Hirayama Y, Sakihama S, Kikuchi T, Hirohashi Y, Tsujiwaki M, Karube K, Hasegawa T, Torigoe T (2022) Spindle cell tumor with histiocytic and myogenic marker expression in the lymph node of a human T-cell leukemia virus type 1 carrier. Pathol Res Pract 234:153935","journal-title":"Pathol Res Pract"},{"key":"2041_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-024-06887-5","volume":"17","author":"A Letafati","year":"2024","unstructured":"Letafati A, Bahavar A, Norouzi M, Rasouli A, Hedayatyaghoubi M, Molaverdi G, Mozhgani S-H, Siami Z (2024) Effects of HTLV-1 on leukocyte trafficking and migration in ACs compared to healthy individuals. BMC Res Notes 17:222","journal-title":"BMC Res Notes"},{"key":"2041_CR23","doi-asserted-by":"publisher","first-page":"115233","DOI":"10.1016\/j.ejmech.2023.115233","volume":"250","author":"Z LI","year":"2023","unstructured":"Li Z, Qiao X, Liu XM, Shi SH, Qiao X, Xu JY (2023) Blocking xCT and PI3K\/Akt pathway synergized with DNA damage of Riluzole-Pt(IV) prodrugs for cancer treatment. Eur J Med Chem 250:115233","journal-title":"Eur J Med Chem"},{"key":"2041_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jtbi.2014.02.022","volume":"352","author":"AG LIM","year":"2014","unstructured":"Lim ag, Maini PK (2014) HTLV-I infection: a dynamic struggle between viral persistence and host immunity. J Theor Biol 352:92\u2013108","journal-title":"J Theor Biol"},{"key":"2041_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178549","volume":"12","author":"S Luo","year":"2017","unstructured":"Luo S, Cao N, Tang Y, Gu W (2017) Identification of key microRNAs and genes in preeclampsia by bioinformatics analysis. PLoS One 12:e0178549","journal-title":"PLoS One"},{"key":"2041_CR26","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3324\/haematol.2020.274258","volume":"107","author":"MCJ Ma","year":"2022","unstructured":"Ma MCJ, Tadros S, Bouska A, Heavican T, Yang H, Deng Q, Moore D, Akhter A, Hartert K, Jain N, Showell J, Ghosh S, Street L, Davidson M, Carey C, Tobin J, Perumal D, Vose JM, Lunning MA, Sohani AR, Chen BJ, Buckley S, Nastoupil LJ, Davis RE, Westin JR, Fowler NH, Parekh S, Gandhi M, Neelapu S, Stewart D, Bhalla K, Iqbal J, Greiner T, Rodig SJ, Mansoor A, Green MR (2022) Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma. Haematologica 107:690\u2013701","journal-title":"Haematologica"},{"key":"2041_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00262-008-0528-z","volume":"58","author":"L Machado","year":"2009","unstructured":"Machado L, Jarrett R, Morgan S, Murray P, Hunter B, Hamilton E, Crocker J, Thomas W, Steven N, Ismail T, Chapman A, Adams DH, Lee SP (2009) Expression and function of T cell homing molecules in Hodgkin\u2019s lymphoma. Cancer Immunol Immunother 58:85\u201394","journal-title":"Cancer Immunol Immunother"},{"key":"2041_CR28","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1182\/blood.2023021788","volume":"144","author":"E Marchi","year":"2024","unstructured":"Marchi E, Craig JW, Kalac M (2024) Current and upcoming treatment approaches to uncommon subtypes of PTCL (EATL, MEITL, SPTCL, and HSTCL). Blood 144:1898\u20131909","journal-title":"Blood"},{"key":"2041_CR29","doi-asserted-by":"crossref","unstructured":"Montes-Mojarro IA, Fend F, Quintanilla-Martinez L (2021) EBV and the Pathogenesis of NK\/T Cell Lymphoma. Cancers (Basel), 13","DOI":"10.3390\/cancers13061414"},{"key":"2041_CR30","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1089\/088922299310728","volume":"15","author":"M Moriuchi","year":"1999","unstructured":"Moriuchi M, Moriuchi H, Fauci AS (1999) HTLV type I tax activation of the CXCR4 promoter by association with nuclear respiratory factor I. AIDS Res Hum Retroviruses 15:821\u2013827","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2041_CR31","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/jmv.24721","volume":"89","author":"SH Mozhgani","year":"2017","unstructured":"Mozhgani SH, Jaberi N, Bustani REZAEESA, Jazayeri R, Akbarin SM, Tarokhian MMMILANIS, H., Norouzi M (2017) Evaluation of HTLV-1 HBZ and proviral load, together with host IFN lambda3, in pathogenesis of HAM\/TSP. J Med Virol 89:1102\u20131107","journal-title":"J Med Virol"},{"key":"2041_CR32","doi-asserted-by":"crossref","unstructured":"Nakahata S, Ichikawa T, Maneesaay P, Saito Y, Nagai K, Tamura T, Manachai N, Kitabayashi YAMAKAWANHAMASAKIM, Arai I, Kanai Y, TAki Y, Abe T, Kiyonari T, Shimoda H, Ohshima K, Shima KHORIIA, Taniwaki H, Yamaguchi M, Morishita R (2014) K Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers. Nat Commun, 5","DOI":"10.1038\/ncomms4393"},{"key":"2041_CR33","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1016\/j.exphem.2015.06.204","volume":"43","author":"S Nakahata","year":"2015","unstructured":"Nakahata S, Ichikawa T, Yusuke S, Arai Y, Taki T, Taniwaki M, Morishita K (2015) Down-Regulation of Ndrg2 Plays an Important Role in Atll Leukemogenesis Via the Pten-Mediated Pi3k\/Akt Signaling Pathway. Exp Hematol 43:S83\u2013S83","journal-title":"Exp Hematol"},{"key":"2041_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12030492","author":"T Nakamura","year":"2023","unstructured":"Nakamura T (2023) HAM\/TSP pathogenesis: the transmigration activity of HTLV-1-infected T cells into tissues. Pathogens. https:\/\/doi.org\/10.3390\/pathogens12030492","journal-title":"Pathogens"},{"key":"2041_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012415","author":"L Necula","year":"2022","unstructured":"Necula L, Matei L, Dragu D, Pitica I, Neagu A, Bleotu C, Diaconu CC, Chivu-Economescu M (2022) Collagen family as promising biomarkers and therapeutic targets in cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232012415","journal-title":"Int J Mol Sci"},{"key":"2041_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011928","volume":"18","author":"S Nozuma","year":"2024","unstructured":"Nozuma S, Yoshimura A, Pai SC, Chen HJ, Matsuura E, Tanaka M, Kodama D, Dozono M, Matsuzaki T, Takashima H, Yang YC, Kubota R (2024) Geographic characteristics of HTLV-1 molecular subgroups and genetic substitutions in East Asia: insights from complete genome sequencing of HTLV-1 strains isolated in Taiwan and Japan. PLoS Negl Trop Dis 18:e0011928","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl 1","key":"2041_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000431058","volume":"89","author":"K Ohshima","year":"2015","unstructured":"Ohshima K (2015) Molecular Pathology of Adult T-Cell Leukemia\/Lymphoma. Oncology 89(Suppl 1):7\u201315","journal-title":"Oncology"},{"key":"2041_CR38","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v126.23.4124.4124","author":"G Pavlasova","year":"2015","unstructured":"Pavlasova G, Seda V, Borsky M, Cerna K, Osickova J, Mayer J, Pospisilova S, Davids MS, Brown JR, Mraz M (2015) Microenvironmental interactions up-regulate CD20 expression in CLL B cells through the CXCR4\/SDF-1 axis: implications for CD20-targeting antibodies and the use of BCR-inhibitors in combination. Blood. https:\/\/doi.org\/10.1182\/blood.v126.23.4124.4124","journal-title":"Blood"},{"key":"2041_CR39","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1182\/blood-2016-04-709519","volume":"128","author":"G Pavlasova","year":"2016","unstructured":"Pavlasova G, Borsky M, Seda V, Cerna K, Osickova J, Doubek M, Mayer J, Calogero R, Trbusek M, Pospisilova S, Davids MS, Kipps TJ, Brown JR, Mraz M (2016) Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4\/SDF-1 axis. Blood 128:1609\u20131613","journal-title":"Blood"},{"key":"2041_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120969","volume":"10","author":"F Qiu","year":"2015","unstructured":"Qiu F, Sun R, Deng N, Guo T, Cao Y, Yu Y, Wang X, Zou B, Zhang S, Jing T, Ling T, Xie J, Zhang Q (2015) MiR-29a\/b enhances cell migration and invasion in nasopharyngeal carcinoma progression by regulating SPARC and COL3A1 gene expression. PLoS One 10:e0120969","journal-title":"PLoS One"},{"key":"2041_CR41","doi-asserted-by":"publisher","first-page":"7479","DOI":"10.1007\/s11033-023-08626-8","volume":"50","author":"M Rahimzada","year":"2023","unstructured":"Rahimzada M, Nahavandi M, Saffari M, Shafaei A, Mosavat A, Ahmadi Gezeldasht S, Ariaee N, Valizadeh N, Rahimi H, Rezaee SA, Derakhshan M (2023) Gene expression study of host-human T-cell leukaemia virus type 1 (HTLV-1) interactions: adult T-cell leukaemia\/lymphoma (ATLL). Mol Biol Rep 50:7479\u20137487","journal-title":"Mol Biol Rep"},{"key":"2041_CR42","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00430-017-0506-1","volume":"206","author":"S Ramezani","year":"2017","unstructured":"Ramezani S, Shirdel A, Rafatpanah H, Akbarin MM, Tarokhian H, Rahimi H, Bari A, Jahantigh HR, Rezaee SA (2017) Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia\/lymphoma. Med Microbiol Immunol 206:327\u2013335","journal-title":"Med Microbiol Immunol"},{"key":"2041_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105622","volume":"169","author":"S Ramezani","year":"2022","unstructured":"Ramezani S, Rezaee SA, Farjami Z, Ebrahimi N, Abdullabass HK, Ibrahim Jebur MI, Rafatpanah H, Akbarin MM (2022) HTLV, a multi organ oncovirus. Microb Pathog 169:105622","journal-title":"Microb Pathog"},{"key":"2041_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.semcancer.2014.04.004","volume":"26","author":"AB Rickinson","year":"2014","unstructured":"Rickinson AB (2014) Co-infections, inflammation and oncogenesis: future directions for EBV research. Semin Cancer Biol 26:99\u2013115","journal-title":"Semin Cancer Biol"},{"key":"2041_CR45","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1038\/s41598-019-39424-7","volume":"9","author":"B Sarkar","year":"2019","unstructured":"Sarkar B, Nishikata I, Nakahata S, Ichikawa T, Shiraga T, Fujii SAHAHR, Tanaka M, Shimoda Y, K., Morishita K (2019) Degradation of p47 by autophagy contributes to CADM1 overexpression in ATLL cells through the activation of NF-kappaB. Sci Rep 9:3491","journal-title":"Sci Rep"},{"issue":"1","key":"2041_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12977-019-0502-1","volume":"16","author":"S Sarkis","year":"2019","unstructured":"Sarkis S, Galli V, Moles R, Yurick D, Khoury G, Purcell DFJ, Franchini G, Pise-Masison CA (2019) Role of HTLV-1 orf-I encoded proteins in viral transmission and persistence. Retrovirology 16:43","journal-title":"Retrovirology"},{"key":"2041_CR47","doi-asserted-by":"publisher","first-page":"1653384","DOI":"10.3389\/fmed.2025.1653384","volume":"12","author":"S Shegefti","year":"2025","unstructured":"Shegefti S, Alaei M, Ghahari N, Telittchenko R, Hanafi SB, Isnard S, Routy JP, Olagnier D, Van Grevenynghe J (2025) Sustained inflammation during human T-lymphotropic virus type 1 infection: a wildfire contributing to disease progression. Front Med (Lausanne) 12:1653384","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"2041_CR48","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1186\/s12885-018-5209-5","volume":"18","author":"H Tarokhian","year":"2018","unstructured":"Tarokhian H, Rahimi H, Mosavat A, Shirdel A, Rafatpanah H, Akbarin MM, Bari A, Ramezani S, Rezaee SA (2018) HTLV-1-host interactions on the development of adult T cell leukemia\/lymphoma: virus and host gene expressions. BMC Cancer 18:1287","journal-title":"BMC Cancer"},{"key":"2041_CR49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1752-0509-6-97","volume":"6","author":"E Tejera","year":"2012","unstructured":"Tejera E, Bernardes, J., Rebelo I (2012) Preeclampsia: a bioinformatics approach through protein-protein interaction networks analysis. BMC Syst Biol 6:97","journal-title":"BMC Syst Biol"},{"key":"2041_CR51","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/pro6.70018","volume":"9","author":"X Wang","year":"2025","unstructured":"Wang X, Wei H, Liu D, Wang H, Li Z, Xing L (2025) Peripheral T-cell lymphoma with central nervous system involvement and elevated interleukin-10 levels in the cerebrospinal fluid: A case report. Precis Radiat Oncol 9:223\u2013227","journal-title":"Precis Radiat Oncol"},{"key":"2041_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1101441","volume":"13","author":"J Weiss","year":"2023","unstructured":"Weiss J, Reneau J, Wilcox RA (2023) PTCL, NOS: an update on classification, risk-stratification, and treatment. Front Oncol 13:1101441","journal-title":"Front Oncol"},{"key":"2041_CR53","doi-asserted-by":"crossref","unstructured":"Witzig TE, SokoL L, Foss FM, Kim WS, De la Cruz JACOBSENE, Caballero MD, De DADVANIRHRONCEROJM, O\u00f1a R, Niebla AM, Terol IZQUIERDOAR, Domingo-Domenech MJ, Rodriguez EPIRISMA, Kessler MBOLOGNESEJ, Mishra L, Curry V, Kurman R, Scholz M, Gualberto C A (2019) Proof of Concept for Tipifarnib in Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL) and CXCL12\u2009+\u2009Peripheral T-Cell Lymphoma (PTCL): Preliminary Results from an Open-Label, Phase 2 Study. Blood, 134","DOI":"10.1182\/blood-2019-128513"},{"key":"2041_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-023-01297-w","volume":"18","author":"Y Yin","year":"2023","unstructured":"Yin Y, Liu H, Luo M, Yu G, Yin W, Li P (2023) Primary extranodal soft tissue Lennert lymphoma (lymphoepithelioid variant of peripheral T-cell lymphoma, unspecified): a case report and review of the literature. Diagn Pathol 18:12","journal-title":"Diagn Pathol"},{"key":"2041_CR55","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12985-021-01643-8","volume":"18","author":"M Zarei Ghobadi","year":"2021","unstructured":"Zarei Ghobadi M, Teymoori-Rad EMAMZADEHR, M., Mozhgani SH (2021) Decoding pathogenesis factors involved in the progression of ATLL or HAM\/TSP after infection by HTLV-1 through a systems virology study. Virol J 18:175","journal-title":"Virol J"},{"key":"2041_CR56","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3389\/fmicb.2020.00421","volume":"11","author":"R Zargari","year":"2020","unstructured":"Zargari R, Mahdifar M, Vahidi MOHAMMADIA, Hassanshahi Z, G., Rafatpanah H (2020) The Role of Chemokines in the Pathogenesis of HTLV-1. Front Microbiol 11:421","journal-title":"Front Microbiol"},{"key":"2041_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28424","volume":"95","author":"X Zuo","year":"2023","unstructured":"Zuo X, Zhou R, Yang S, Ma G (2023) HTLV-1 persistent infection and ATLL oncogenesis. J Med Virol 95:e28424","journal-title":"J Med Virol"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-02041-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-02041-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-02041-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:27:13Z","timestamp":1788931633000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-026-02041-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2041"],"URL":"https:\/\/doi.org\/10.1007\/s10142-026-02041-5","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This is an observational study. The UNAM Research Ethics Committee has confirmed that no ethical approval is required for this research.","order":1,"name":"Ethics","label":"Ethical Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":4,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"257"}}